Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

17.1K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.1K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

9.9K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel CD7-directed antibody-drug conjugate targeting BCL-XL with potent anti-leukemic activity in T-cell acute lymphoblastic leukemia.

Leukemia·2026
Same author

AML halts neutrophil maturation.

Blood·2025
Same author

FOXP1 contributes to murine hematopoietic stem cell functionality.

Experimental hematology·2025
Same author

Intravital Longitudinal Imaging of Vascular Dynamics in the Calvarial Bone Marrow.

Journal of visualized experiments : JoVE·2025
Same author

Targeting the TNF/IAP pathway synergizes with anti-CD3 immunotherapy in T-cell acute lymphoblastic leukemia.

Blood·2024
Same author

Breast cancer remotely imposes a myeloid bias on haematopoietic stem cells by reprogramming the bone marrow niche.

Nature cell biology·2023

Related Experiment Video

Updated: Mar 22, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.7K

Microenvironmental cues for T-cell acute lymphoblastic leukemia development.

Diana Passaro1, Christine Tran Quang2,3, Jacques Ghysdael2,3

  • 1Hematopoietic Stem Cell Laboratory, The Francis Crick Institute, Lincoln's Inn Fields Laboratories, London, UK.

Immunological Reviews
|April 19, 2016
PubMed
Summary

Despite chemotherapy advances, T-cell acute lymphoblastic leukemia (T-ALL) remains challenging due to treatment resistance. This review explores how T-ALL cells exploit bone marrow and thymic niches for survival and proliferation, offering new therapeutic avenues.

Keywords:
T-cell acute lymphoblastic leukemialeukemic nicheoncogenesignalingtargeted therapytumor microenvironment

More Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

827
Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact
11:29

Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact

Published on: July 17, 2016

29.0K

Related Experiment Videos

Last Updated: Mar 22, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.7K
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

827
Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact
11:29

Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact

Published on: July 17, 2016

29.0K

Area of Science:

  • Hematology
  • Cancer Biology
  • Immunology

Background:

  • Intensive chemotherapy has improved T-cell acute lymphoblastic leukemia (T-ALL) cure rates, but treatment resistance and relapse remain significant challenges, particularly in adults.
  • T-ALL is a heterogeneous malignancy characterized by aberrant transcription factor expression and genetic mutations affecting cell development, proliferation, and apoptosis.
  • Molecular subtyping of T-ALL based on gene expression reveals differentiation arrest stages, yet this has not yielded targeted therapies.

Purpose of the Study:

  • To review the interactions between hematopoietic cells and bone marrow/thymic niches in normal hematopoiesis.
  • To describe key signaling pathways involved in the dialog between hematopoietic cells and their niches.
  • To highlight the dependence of malignant T cells on specific niches for leukemia propagation.

Main Methods:

  • Literature review of studies on normal hematopoiesis and T-ALL.
  • Analysis of gene expression profiling data for T-ALL classification.
  • Investigation of signaling pathways in hematopoietic stem/progenitor cell development and T-ALL.

Main Results:

  • T-ALL exhibits molecular heterogeneity linked to differentiation arrest.
  • Extrinsic signaling cues from hematopoietic niches are crucial for T-ALL cell homing, survival, and proliferation.
  • Malignant T cells leverage specific niche interactions to sustain and propagate leukemia.

Conclusions:

  • Understanding the interplay between T-ALL cells and their microenvironment is critical for developing novel therapeutic strategies.
  • Targeting niche-mediated survival and proliferation mechanisms presents a promising avenue for overcoming treatment resistance in T-ALL.
  • Further research into the specific signaling pathways and niche components exploited by T-ALL could lead to more effective therapies.